DAM
ABBV icon

Doheny Asset Management’s AbbVie ABBV Stock Holding History

Doheny Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.39M Sell
15,594
-1,739
-10% -$386K 2.21% 15
2025
Q4 		$3.96M Hold
17,333
– – 2.42% 11
2025
Q3 		$4.01M Hold
17,333
– – 2.55% 9
2025
Q2 		$3.22M Hold
17,333
– – 2.25% 11
2025
Q1 		$3.63M Hold
17,333
– – 2.84% 8
2024
Q4 		$3.08M Sell
17,333
-300
-2% -$55.2K 2.3% 13
2024
Q3 		$3.48M Sell
17,633
-88
-0.5% -$16.4K 2.38% 13
2024
Q2 		$3.04M Hold
17,721
– – 2.17% 15
2024
Q1 		$3.23M Buy
17,721
+1,536
+9% +$265K 2.65% 11
2023
Q4 		$2.51M Sell
16,185
-1,500
-8% -$219K 2.46% 12
2023
Q3 		$2.64M Sell
17,685
-2,600
-13% -$382K 2.56% 13
2023
Q2 		$2.73M Sell
20,285
-150
-0.7% -$22K 2.34% 12
2023
Q1 		$3.26M Buy
20,435
+3,482
+21% +$532K 2.92% 7
2022
Q4 		$2.74M Sell
16,953
-4,181
-20% -$641K 3.18% 6
2022
Q3 		$2.84M Buy
+21,134
New +$3.03M 2.84% 6
2022
Q1 		$3.56M Sell
21,978
-100
-0.5% -$14.5K 2.6% 9
2021
Q4 		$2.99M Sell
22,078
-2,370
-10% -$280K 2.1% 15
2021
Q3 		$2.64M Sell
24,448
-1,960
-7% -$224K 1.89% 16
2021
Q2 		$2.98M Sell
26,408
-515
-2% -$58K 1.92% 14
2021
Q1 		$2.91M Buy
26,923
+1,940
+8% +$208K 1.98% 12
2020
Q4 		$2.68M Buy
24,983
+5,810
+30% +$558K 1.86% 14
2020
Q3 		$1.68M Buy
+19,173
New +$1.81M 1.39% 25
2016
Q1 		– Sell
-5,400
Closed -$320K – 103
2015
Q4 		$320K Sell
5,400
-1,000
-16% -$57.6K 0.16% 81
2015
Q3 		$348K Buy
6,400
+1,000
+19% +$65.1K 0.18% 81
2015
Q2 		$363K Hold
5,400
– – 0.16% 88
2015
Q1 		$316K Hold
5,400
– – 0.15% 89
2014
Q4 		$353K Buy
+5,400
New +$340K 0.17% 86

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Doheny Asset Management's ABBV Position: Q1 2026 in Review

Doheny Asset Management reduced its AbbVie (ABBV) stake by 10% in Q1 2026, selling an estimated $386K and leaving 15,594 shares worth $3.39M. The position accounts for 2.21% of the portfolio, ranked #15.

Doheny Asset Management first reported a position in ABBV in Q4 2014 and has held it in 27 quarters since. The position peaked at $4.01M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Doheny Asset Management held 15,594 shares of AbbVie worth $3.39M as of Q1 2026.
  • Doheny Asset Management sold 1,739 AbbVie shares in Q1 2026, an estimated $386K.
  • AbbVie made up 2.21% of Doheny Asset Management's portfolio in Q1 2026, its #15 holding.
  • Doheny Asset Management first reported a position in AbbVie in Q4 2014 and has held it in 27 quarters since.
  • Doheny Asset Management's AbbVie position peaked at $4.01M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Doheny Asset Management's 13F filing for Q1 2026, filed 7 May 2026.